CASI Pharmaceuticals, Inc. (CASI)

CASI Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	33.88	33.88	43.11	30.17	15.14	4.13
Revenue Growth (YoY)	-21.41%	-21.41%	42.89%	99.25%	266.52%	-
Cost of Revenue	13.83	13.83	15.83	12.56	9.51	3.94
Gross Profit	20.05	20.05	27.28	17.61	5.63	0.2
Selling, General & Admin	41.84	41.84	37.78	38.41	27.48	30.44
Research & Development	9.86	9.86	16	14.42	11.47	9.34
Other Operating Expenses	-6.37	-6.37	10.78	6.62	18.21	7.38
Operating Expenses	45.33	45.33	64.55	59.45	57.16	47.15
Operating Income	-25.28	-25.28	-37.27	-41.84	-51.53	-46.96
Other Expense / Income	1.74	1.74	1.76	-5.18	-3.24	-0.93
Pretax Income	-27.02	-27.02	-39.03	-36.65	-48.29	-46.03
Income Tax	-0.08	-0.08	1.98	0	0	0
Net Income	-26.94	-26.94	-41.01	-36.65	-48.29	-46.03
Preferred Dividends	0.02	0.02	0	0	0	0
Net Income Common	-26.96	-26.96	-41.01	-36.65	-48.29	-46.03
Shares Outstanding (Basic)	13	13	14	14	11	10
Shares Outstanding (Diluted)	13	13	14	14	11	10
Shares Change	-2.10%	-2.10%	0.27%	23.23%	15.12%	13.21%
EPS (Basic)	-2.02	-2.02	-3.01	-2.69	-4.37	-4.80
EPS (Diluted)	-2.02	-2.02	-3.01	-2.69	-4.37	-4.80
Free Cash Flow	-22.21	-22.21	-26.56	-35.78	-24.69	-30.3
Free Cash Flow Per Share	-1.66	-1.66	-1.95	-2.63	-2.23	-3.16
Gross Margin	59.19%	59.19%	63.28%	58.38%	37.20%	4.74%
Operating Margin	-74.62%	-74.62%	-86.47%	-138.68%	-340.31%	-1136.72%
Profit Margin	-79.58%	-79.58%	-95.14%	-121.50%	-318.92%	-1114.31%
Free Cash Flow Margin	-65.55%	-65.55%	-61.62%	-118.59%	-163.03%	-733.38%
EBITDA	-22.29	-22.29	-35.42	-33.56	-45.06	-43.46
EBITDA Margin	-65.79%	-65.79%	-82.17%	-111.24%	-297.58%	-1051.92%
Depreciation & Amortization	4.73	4.73	3.61	3.1	3.23	2.58
EBIT	-27.02	-27.02	-39.03	-36.65	-48.29	-46.03
EBIT Margin	-79.75%	-79.75%	-90.55%	-121.50%	-318.92%	-1114.31%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).